Correlation Engine 2.0
Clear Search sequence regions


  • 4 and (2)
  • blood (1)
  • c57bl mice (1)
  • cell (1)
  • colon (2)
  • female (1)
  • FGF7 (3)
  • fibroblast growth factors (12)
  • fibroblasts (1)
  • graft (4)
  • IL 18 (1)
  • injuries (1)
  • jejunum (2)
  • kaplan meier estimate (1)
  • lethal dose 50 (1)
  • male (1)
  • mice (4)
  • partial (4)
  • PF4 (6)
  • PF7 (5)
  • plasma (2)
  • polymers (2)
  • Sizes of these terms reflect their relevance to your search.

    We evaluated the mitigating effects of fibroblast growth factor 4 and 7 (FGF4 and FGF7, respectively) in comparison with long acting protected graft copolymer (PGC)-formulated FGF4 and 7 (PF4 and PF7, respectively) administered to C57BL/6J mice a day after exposure to LD50/30 (15.7 Gy) partial body irradiation (PBI) which targeted the gastrointestinal (GI) system. The PGC that we developed increased the bioavailability of FGF4 and FGF7 by 5- and 250-fold compared to without PGC, respectively, and also sustained a 24 hr presence in the blood after a single subcutaneous administration. The dose levels tested for mitigating effects on radiation injury were 3 mg/kg for the PF4 and PF7 and 1.5 mg each for their combination (PF4/7). Amifostine administered prior to PBI was used as a positive control. The PF4, PF7, or PF4/7 mitigated the radiation lethality in mice. The mitigating effect of PF4 and PF7 was similar to the positive control and PF7 was better than other mitigators tested. The plasma citrulline levels and hematology parameters were early markers of recovery and survival. GI permeability function appeared to be a late or full recovery indicator. The villus length and crypt number correlated with plasma citrulline level, indicating that it can act as a surrogate marker for these histology evaluations. The IL-18 concentrations in jejunum as early as day 4 and TPO levels in colon on day 10 following PBI showed statistically significant changes in irradiated versus non-irradiated mice which makes them potential biomarkers of radiation exposure. Other colon and jejunum cytokine levels are potentially useful but require larger numbers of samples than in the present study before their full utility can be realized.

    Citation

    Gerardo M Castillo, Akiko Nishimoto-Ashfield, Cynthia C Jones, Kasim K Kabirov, Alexander Zakharov, Alexander V Lyubimov. Protected graft copolymer-formulated fibroblast growth factors mitigate the lethality of partial body irradiation injury. PloS one. 2017;12(2):e0171703

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 28207794

    View Full Text